Click each day to view the schedule. Sessions are subject to change.
All Summit sessions will be available On Demand post event.
Chair Len Monheit will provide an overview of the Summit and share some market insights on this exploding category.
An open call for collaborative efforts to champion regulatory understanding of pre and postbiotics. Take a journey with case studies from Kyowa Hakko Bio on their journey of commercializing IMMUSE, an award-winning postbiotic, and Human Milk Oligosaccharides, a promising prebiotic.
Discussing the mechanism of diet-microbiota-host interactions in gut-brain axis signalling. Also the strategies we have setup in lab to identify novel microbiota-targeted approaches (diet, pre and probiotics) to mobilise the second generation of bacteria for better metabolic and mental health. Using the b.longum as example of how we can screen pre and probiotic ingredients across targets in the gut brain axis.
To deal with the chronic disease issues of the 21st century, healthcare must increasingly focus on enhancing wellness and minimizing transition to disease — what Lee Hood and I have called Scientific Wellness (The Age of Scientific Wellness, Harvard Press). To enable scientific wellness, it is necessary to generate large amounts of data on healthy people to quantify the health phenotype and to observe the earliest transitions to disease in order to enable prediction and prevention. Deepening our understanding of the many health effects of the microbiome — and making it actionable to improve people’s health — is central to this transformation. I will discuss how such longitudinal 'deep phenotyping’ data has been used to: (1) inform about how our gut microbiome and blood metabolites are related; (2) how the gut microbiome becomes more unique to each individual in healthy aging (3) how the microbiome predicts both efficacy and side effects of statins (4) microbiome differences that were associated with weight loss success or not in a personalized wellness program and (5) how new technological advances such as Thorne’s ‘microbiome wipe’ and OneDraw blood collection device are making user experiences much easier to aid with broader adoption. Taken together, such approaches hold tremendous promise for the future of health optimization and preventive healthcare contextualized to each person’s unique microbiome, genome, lifestyle, and health history.
The microbiome product & testing space has become more competitive in the last 12 months. High growth brands have expanded their marketshare across supplement and F&B, while new entrants seeing trends have launched products or services. We’ll start off by revisiting 2021 trend predictions to see understand what actually occurred vs what didn’t happen. Then the focus shifts to 2023 for predictions, specifically how adjacent sectors like digital health & healthcare are looking to enter the space.